Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...

Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...

Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

Australia’s most revered medical researchers are crying out for funding to cure deadly diseases while taxpayers fork out more ...

Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...

Arschang Valipour, head of Internal Medicine and Pulmonology at the Floridsdorf Clinic, presented a bronchoscopy robot this ...

How does preventing cirrhosis lower the risk of liver cancer mortality? Early intervention, viral hepatitis treatment, and ...

For more than two decades, oncologists treating advanced pancreatic cancer have watched new drugs fail to move the survival ...